Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE27.3400
- TODAY'S CHANGE (%)0.1000 (0.3671%)
- Bid / Lots25.0500/ 18
- Ask / Lots29.9500/ 10
- Open / Previous Close27.1200 / 27.2400
- Day Range
- 52 Week Range
- Volume806,669
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 5238 | 27.155 |
| 09:33 ET | 1471 | 27.06 |
| 09:35 ET | 600 | 26.88 |
| 09:39 ET | 1965 | 26.8187 |
| 09:44 ET | 800 | 26.75 |
| 09:46 ET | 900 | 26.76 |
| 09:48 ET | 1100 | 27.07 |
| 09:50 ET | 4702 | 27.14 |
| 09:51 ET | 990 | 26.975 |
| 09:55 ET | 900 | 26.985 |
| 09:57 ET | 800 | 27.085 |
| 10:00 ET | 100 | 27.13 |
| 10:02 ET | 400 | 27.17 |
| 10:04 ET | 1455 | 27.14 |
| 10:06 ET | 1205 | 27.29 |
| 10:08 ET | 2900 | 27.195 |
| 10:09 ET | 10882 | 27.125 |
| 10:11 ET | 900 | 27.2 |
| 10:13 ET | 27114 | 27.275 |
| 10:15 ET | 2751 | 27.5201 |
| 10:18 ET | 909 | 27.545 |
| 10:20 ET | 1617 | 27.4 |
| 10:22 ET | 2171 | 27.37 |
| 10:27 ET | 1975 | 27.22 |
| 10:29 ET | 400 | 27.155 |
| 10:31 ET | 500 | 27.155 |
| 10:33 ET | 500 | 27.335 |
| 10:38 ET | 200 | 27.4 |
| 10:40 ET | 2110 | 27.4 |
| 10:42 ET | 100 | 27.45 |
| 10:44 ET | 500 | 27.5 |
| 10:45 ET | 3247 | 27.39 |
| 10:47 ET | 600 | 27.4 |
| 10:49 ET | 1263 | 27.4 |
| 10:51 ET | 700 | 27.57 |
| 10:54 ET | 300 | 27.475 |
| 10:56 ET | 100 | 27.475 |
| 10:58 ET | 787 | 27.46 |
| 11:00 ET | 400 | 27.44 |
| 11:02 ET | 16647 | 27.48 |
| 11:03 ET | 1097 | 27.56 |
| 11:05 ET | 4149 | 27.51 |
| 11:07 ET | 600 | 27.4 |
| 11:09 ET | 500 | 27.23 |
| 11:12 ET | 100 | 27.19 |
| 11:14 ET | 1797 | 27.265 |
| 11:18 ET | 100 | 27.29 |
| 11:20 ET | 100 | 27.32 |
| 11:21 ET | 145 | 27.2704 |
| 11:23 ET | 221 | 27.39 |
| 11:25 ET | 9910 | 27.31 |
| 11:34 ET | 1948 | 27.24 |
| 11:36 ET | 200 | 27.27 |
| 11:38 ET | 300 | 27.32 |
| 11:39 ET | 200 | 27.36 |
| 11:48 ET | 100 | 27.29 |
| 11:50 ET | 100 | 27.34 |
| 11:52 ET | 500 | 27.39 |
| 11:54 ET | 4000 | 27.57 |
| 11:56 ET | 2544 | 27.51 |
| 11:57 ET | 400 | 27.49 |
| 11:59 ET | 300 | 27.43 |
| 12:01 ET | 216 | 27.45 |
| 12:06 ET | 200 | 27.46 |
| 12:08 ET | 991 | 27.34 |
| 12:10 ET | 100 | 27.38 |
| 12:14 ET | 500 | 27.27 |
| 12:15 ET | 532 | 27.26 |
| 12:19 ET | 100 | 27.305 |
| 12:21 ET | 100 | 27.36 |
| 12:24 ET | 100 | 27.43 |
| 12:26 ET | 325 | 27.4 |
| 12:28 ET | 100 | 27.475 |
| 12:30 ET | 100 | 27.47 |
| 12:32 ET | 100 | 27.47 |
| 12:37 ET | 647 | 27.49 |
| 12:39 ET | 100 | 27.54 |
| 12:42 ET | 800 | 27.56 |
| 12:44 ET | 17600 | 27.6 |
| 12:46 ET | 300 | 27.62 |
| 12:48 ET | 303 | 27.67 |
| 12:50 ET | 300 | 27.7 |
| 12:51 ET | 900 | 27.65 |
| 12:53 ET | 100 | 27.65 |
| 12:55 ET | 300 | 27.655 |
| 01:00 ET | 663 | 27.58 |
| 01:02 ET | 100 | 27.6 |
| 01:04 ET | 4500 | 27.4 |
| 01:08 ET | 100 | 27.41 |
| 01:09 ET | 100 | 27.375 |
| 01:11 ET | 200 | 27.34 |
| 01:13 ET | 550 | 27.34 |
| 01:15 ET | 300 | 27.36 |
| 01:18 ET | 1098 | 27.375 |
| 01:20 ET | 7500 | 27.28 |
| 01:22 ET | 4548 | 27.13 |
| 01:24 ET | 200 | 27.1 |
| 01:26 ET | 132 | 27.02 |
| 01:27 ET | 200 | 27.04 |
| 01:29 ET | 1350 | 27.05 |
| 01:31 ET | 200 | 27.055 |
| 01:33 ET | 100 | 27.06 |
| 01:36 ET | 1280 | 27.135 |
| 01:38 ET | 757 | 27.235 |
| 01:40 ET | 786 | 27.31 |
| 01:42 ET | 1011 | 27.31 |
| 01:44 ET | 100 | 27.295 |
| 01:45 ET | 1400 | 27.37 |
| 01:47 ET | 600 | 27.3556 |
| 01:49 ET | 3106 | 27.3147 |
| 01:51 ET | 500 | 27.315 |
| 01:54 ET | 200 | 27.315 |
| 01:56 ET | 264 | 27.31 |
| 02:00 ET | 4343 | 27.315 |
| 02:02 ET | 1215 | 27.18 |
| 02:03 ET | 530 | 27.09 |
| 02:05 ET | 100 | 27.08 |
| 02:07 ET | 200 | 27.08 |
| 02:09 ET | 200 | 27.075 |
| 02:12 ET | 300 | 27.08 |
| 02:14 ET | 200 | 27.08 |
| 02:16 ET | 100 | 27.13 |
| 02:18 ET | 600 | 27.04 |
| 02:20 ET | 400 | 27.14 |
| 02:23 ET | 100 | 27.24 |
| 02:25 ET | 500 | 27.26 |
| 02:27 ET | 100 | 27.29 |
| 02:30 ET | 200 | 27.3 |
| 02:32 ET | 781 | 27.365 |
| 02:34 ET | 116 | 27.37 |
| 02:36 ET | 300 | 27.37 |
| 02:38 ET | 3700 | 27.4 |
| 02:39 ET | 300 | 27.37 |
| 02:41 ET | 1000 | 27.38 |
| 02:43 ET | 200 | 27.43 |
| 02:45 ET | 2821 | 27.4 |
| 02:48 ET | 200 | 27.41 |
| 02:50 ET | 400 | 27.43 |
| 02:52 ET | 2296 | 27.46 |
| 02:54 ET | 1561 | 27.54 |
| 02:56 ET | 600 | 27.555 |
| 02:57 ET | 774 | 27.58 |
| 02:59 ET | 300 | 27.67 |
| 03:01 ET | 11555 | 27.63 |
| 03:03 ET | 200 | 27.6 |
| 03:06 ET | 2211 | 27.42 |
| 03:08 ET | 600 | 27.46 |
| 03:10 ET | 800 | 27.465 |
| 03:12 ET | 300 | 27.5 |
| 03:14 ET | 1000 | 27.39 |
| 03:15 ET | 1141 | 27.44 |
| 03:17 ET | 6805 | 27.42 |
| 03:19 ET | 500 | 27.41 |
| 03:21 ET | 500 | 27.47 |
| 03:24 ET | 300 | 27.47 |
| 03:26 ET | 400 | 27.52 |
| 03:28 ET | 1877 | 27.35 |
| 03:30 ET | 200 | 27.38 |
| 03:32 ET | 200 | 27.41 |
| 03:33 ET | 1600 | 27.365 |
| 03:35 ET | 900 | 27.47 |
| 03:37 ET | 1242 | 27.48 |
| 03:39 ET | 800 | 27.5 |
| 03:42 ET | 4910 | 27.41 |
| 03:44 ET | 5565 | 27.45 |
| 03:46 ET | 3000 | 27.395 |
| 03:48 ET | 2619 | 27.335 |
| 03:50 ET | 6082 | 27.41 |
| 03:51 ET | 2750 | 27.33 |
| 03:53 ET | 3407 | 27.38 |
| 03:55 ET | 4134 | 27.36 |
| 03:57 ET | 8331 | 27.41 |
| 04:00 ET | 193496 | 27.34 |
Nov 6, 2024
DJ Nurix Therapeutics Price Target Maintained With a $29.00/Share by Needham, from 6:19AM ET on Wednesday Nov 06, 2024 by Dow Jones
6:19AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting, from 9:01AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:01AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 31, 2024
Nurix Therapeutics to Participate in Upcoming Investor Conferences, from 7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 24, 2024
DJ Nurix Therapeutics Initiated at Buy by UBS, from 7:55AM ET on Thursday Oct 24, 2024 by Dow Jones
7:55AM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 21, 2024
Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit, from 4:00PM ET on Monday Oct 21, 2024 by Dow Jones
4:00PM ET on Monday Oct 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.9B | -9.4x | --- |
Arvinas Inc | 1.9B | -5.7x | --- |
Recursion Pharmaceuticals Inc | 2.0B | -4.6x | --- |
Tarsus Pharmaceuticals Inc | 1.9B | -11.2x | --- |
Disc Medicine Inc | 1.9B | -17.8x | --- |
Intellia Therapeutics Inc | 1.7B | -3.1x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $56.4M |
Shares Outstanding | 70.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.20 |
EPS | $-2.91 |
Book Value | $4.12 |
P/E Ratio | -9.4x |
Price/Sales (TTM) | 34.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -343.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
